Professor

CURRICULUM VITAE

NAME: ROBERT CARLEN SIZEMORE

ADDRESS: ** ********** ** *******, ** 39120

PERSONAL DATA:

Date of Birth: September 30, 1951

Citizenship: U.S.A.

Current Staus: Professor, Retired

EDUCATION:

B.S. (Zoology) University of Kentucky, Lexington, KY, 1973

M.S. (Microbiology) University of Kentucky, Lexington, KY, 1975

Ph.D. (Microbiology & Immunology)

University of Louisville (School of

Medicine), Louisville, KY, 1982

PAST MEMBERSHIPS, APPOINTMENTS, HONORS:

American Association of Immunologists

Advisory Board: ASU-PSU Bridges to the Doctorate Program Alcorn State Director: ASU-PSU Bridges to the Doctorate Program

International Society of Developmental and

Comparative Immunology

International AIDS Society

B.S. Degree - Honors with Distinction

University of Louisville Project Award - 1978

(Institutional Grant)

University of Louisville Graduate Dean's Citation

for the Year 1983

2

Outstanding Young Men of America – 1984

Who's Who in Frontiers of Science and Technology - (Second and Subsequent Editions)

Who's Who in the South and Southwest - (22nd and

Subsequent Editions)

American Men and Women of Science (18th and Subsequent Editions)

Who's Who in the World - (11th and Subsequent Editions) Who's Who in Science and Engineering - (Second Edition and Subsequent Editions)

Who's Who in Medicine and Healthcare - (First Edition and Subsequent Editions)

International Who’s Who of Professionals (1998 Edition) Who’s Who in America (2000 Edition)

Who’s Who Among America’s Teachers (2000 Edition)

HEADWAE Award – Outstanding Faculty Member (Alcorn State University) 2018

PROFESSIONAL AFFILIATIONS:

2003-2022 Alcorn State University,

Department of Biological Sciences

Professor (Retired in 2022)

1996- 2003 Alcorn State University,

Department of Biological Sciences

Associate Professor

Tenured (8/13/01)

1985 -1998 Tulane University School of Medicine,

Department of Microbiology and Immunology,

Adjunct Assistant Professor

3

1994 - 1996 Tulane University School of Medicine

Department of Microbiology and Immunology

Assistant Professor (Special Appointment)

1984 - 1994 IMREG, Inc.,

Director of Immunology 1986-1994

Director of Cellular Immunology II 1985-1986

Research Scientist 1984-1985

1982 - 1984 University of Mississippi Medical Center, Postdoctoral Research Associate

1980 - 1982 University of Louisville, Graduate Service Assistant

1979 - 1980 University of Louisville, Graduate Research Assistant

1978 - 1979 University of Louisville, Graduate Service Assistant

INTRAMURAL SERVICE:

1995-1996 Coordinator of Seminars for the Department of Microbiology & Immunology

Tulane University School of Medicine

Alcorn State Chair – Search Committee for Dean of Arts and Sciences (2009-2010)

Chair – Council on Faculty and Staff Awards

and Recognition (2006)

Chair - 2000 SACS Self-study - Library

Chair - Undergraduate Curriculum Committee,

(Biology Dept. 1999 - 2005)

Chair – Search Committee for New Faculty

(Biology Dept. 2008 - present)

Chair - Committee of Compliance Review on

Graduate Student Research (2005),

4

Faculty Senate (1999 - 2004)

(Vice President 2002 - 2004)

Graduate Council (1999 - present)

Biotechnology Committee (1999 - present)

Pre-professional Advisor (Biology Dept. 1996 -

present)

Graduate Curriculum Committee (Biology Dept.

1999 - present)

MARC Program (Advisor - 2000 - 2008)

ASU Graduate Thesis Handbook Committee

(2000 - present)

ASU Graduate Student and Graduate Faculty

Handbook Committee (2000 - present)

General Education Core Committee (2013 –

present)

SMET Grant (Advisor - 2001 - 2003)

Coordinator - Pre-Graduate School Program

(Pre-Professional School Program) (2003 –

present)

Council on Faculty Development and

Intellectual Renewal

Committee on Graduates/Alumni

HBCU-UP Program – Biotechnology

Coordinator

NATIONAL SERVICE:

1999- 2002 Review Panel, National Institutes of Health MBRS Grants

2025 – present Academic Editor, Journal of Environmental Studies and Health Research

5

GRANT SUPPORT:

Previous NIH/NIGMS (MBRS) Immunomodulation By Metabolites Derived From Enkephalin, PI: Robert Sizemore, 4/1/98-3/31/01 Total direct costs: $485,361

Alcorn State University Faculty Intellectual Renewal Grant

“Immunomodulatory Peptides Derived From Enkephalin”- Travel to Professional Meeting - $1000, Oct. 2000

NIH/NIGMS (SCORE) Immunomodulation By Metabolites Derived From Enkephalin, PI: Robert Sizemore, 4/1/01-3/31/05 Total direct costs: $585,260

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$454. 2008.

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$464. 2009.

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$464. 2010.

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$520. 2011-2012.

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$520. 2013-2014.

Alcorn State University Faculty Intellectual Renewal Grant Membership/Dues for the American Association of Immunonologists,

$520. 2014-2016.

6

PUBLICATIONS:

1. Miller, Richard D., William J. Warren, Robert C. Sizemore and Stephen A. Morse. 1978. Binding of Cholesterol by Neisseria gonorrhoeae. Infect. and Immun. 22:698.

2. Sizemore, Robert C. and John M. Mansfield. 1984. Lymphocyte Function in Experimental African Trypanosomiasis. VII. Loss of Antigen Nonspecific Suppressor T Cell Function. Cell. Immunol. 87:684. 3. Sizemore, Robert C. and John M. Mansfield. 1984. Lymphocyte Function in Experimental African Trypanosomiasis. VIII. Loss of Suppressor T Cell Function in Lymph Nodes. Cell. Immunol. 89:439.

4. Sizemore, Robert C., Norman W. Miller, Marvin A. Cuchens, Craig J. Lobb and L. William Clem. 1984. Phylogeny of Lymphocyte Heterogeneity: The Cellular Requirements for In Vitro Mitogenic Responses of Channel Catfish Leucocytes. J. Immunol. 133:2920.

5. Miller, Norman W., Robert C. Sizemore and L. William Clem. 1985. Phylogeny of Lymphocyte Heterogeneity: The Cellular Requirements for In Vitro Antibody Responses of Channel Catfish Leucocytes. J. Immunol. 134:2884. 6. Clem, L.W., R.C. Sizemore, C.F. Ellsaesser and N.W. Miller. 1985. Monocytes As Accessory Cells In Fish Immune Responses. Dev. Comp. Immunol. 9:803. 7. Sinha, Sudhir K., Robert C. Sizemore and A. Arthur Gottlieb. 1988. Immunomodulatory Components Present in IMREG-1, an Experimental Immunosupportive Biologic. Bio/Technol. 6:810.

8. Gottlieb, A.A., M.S. Gottlieb, S. Sinha, R. Sizemore and C.H. Kern. 1988. Clinical and Immunological Effects of IMREG-1 and IMREG-2, Two Immunoregulators Derived from Leukocytes. Int. J. Immunotherapy IV(4):199. 9. Sizemore, R.C., R.L., Dienglewicz, E. Pecunia, S.K. Sinha and A.A. Gottlieb. 1991. Modulation of Concanavalin A-Induced, Antigen Nonspecific Regulatory Cell Activity by Leu-Enkephalin and Related Peptides. Clin. Immunol. and Immunopath. 60:310.

10. Gottlieb, A.A., M.S. Gottlieb, R.C. Sizemore and C.H. Kern. 1994. Acquired Immunodysregulation (AIDS): Pathomechanisms and Immunorestorative Approaches. Lymphology 27 (suppl): 219.

11. Johnson, Emmett J., Robert C. Sizemore and A. Arthur Gottlieb. 1995. HIV Retrotransposon Activity and the Immunopathogenesis of AIDS. Trends in Microbiol. 3:115.

7

12. Sizemore, Robert C., Clifford H. Kern, Marise S. Gottlieb and A. Arthur Gottlieb. 1995. A Novel Methodology For Quantitating the Enhancement of Cutaneous Delayed-Type Hypersensitivity by IMREG-1: A Measure of the Immunopotentiation of Cell-mediated Immunity. Clin. Immunol. and Immunopath. 76:308.

13. Gottlieb, A. A., R. C. Sizemore, M. S. Gottlieb and C. H. Kern. 1995. Rationale and Clinical Results of Using Leukocyte-Derived Immunosupportive Therapies in HIV Disease. IMREG-1 in HIV disease. Biotherapy 9: 27. 14. Cobb, Angela, LeeTerry Moore, Henry P. Godfrey, Natalia Gordonov, Edward Heilman, and Robert C. Sizemore. 2001. The Use of Hairless (IAF/HA-HO) Guinea Pigs For The Determination of Delayed-type Hypersensitivity To Tuberculin. International Immunopharmacol. 1: 349. 15. Sizemore, Robert C., Marta Piva, LeeTerry Moore, Natalia Gordonov, Edward Heilman, and Henry P. Godfrey. 2004. Modulation of Delayed-type Hypersensitivity Responses in Hairless Guinea Pigs By Peptides Derived From Enkephalin. NeuroImmunoModulation 11: 141.

16. Piva, Marta, J. Ignacio Moreno, Fameeka S. Jenkins, Jimmie K. A. Smith, Jenetria L. Thomas, Corey Montgomery, Caleph B. Wilson, and Robert C. Sizemore. 2005. In vitro Modulation of Cytokine Expression by Enkephalin- derived Peptides. NeuroImmunoModulation 12: 339.

17. August, Avery, Bettaiya Rajanna, and Robert Sizemore, 2008. Bridging the Masters and Doctorate Degrees. ASBMB Today November 2008, pp. 28-29. 18. Sizemore, Robert C. 2012. How Does Stress Affect the Immune System. Cell Develop. Biol. 1: 1-2.

19. Zaman, M.S. and Robert Sizemore. 2016. Zika Virus: Origin Transmission Risk and Prevention. Adv. Sci. Tech. 10 (1&2): 1-4.

20. Zaman, M.S. and Robert Sizemore. 2017. Freshwater Resources Could Become the Most Critical Factor in The Future of The Earth. J. Miss. Acad. Sci. 62 (4): 348-352. 21. Zaman, M.S. and Robert Sizemore. 2017. A Follow-up to Zika Virus: Origin Transmission Risk and Prevention. Adv. Sci. Tech. 11 (1): 1-6. 22. Sizemore, Robert and M. S. Zaman. 2019. Are Squalene-containing Vaccines Potentially Harmful? Adv. Sci. Tech. 12 (1&2): 8-11 8

23. Zaman, M. S., Rakeen Zaman, and Robert C. Sizemore. 2019. Plastic Pollution of the Oceans: A Review of Marine Plastic Pollution and Its Environmental Impacts. Adv. Sci. Tech: 13: 1-8.

24. Zaman, M.S., Robert C. Sizemore and Rakeen S. Zaman. 2019. Microplastics in the Environment: Ecological Interactions and Consequences. Adv. Sci. Tech: 13: 22-28. 25. Sizemore, Robert C. and M.S. Zaman. 2020. Ebola Virus and SARS-Cov-2: Similarites and Differences. J. Health Soc. Sci. 5,2:241-250. 26. Zaman, M. S. and Robert C. Sizemore. 2020. Potential Biological and Health Effects of Nanoplastics. Advances in Science and Technologies, Vol. 14, No 1 & 2, 1 – 7. 27. Zaman, M.S., Robert C. Sizemore, Suleyman Tufa and Max Carlos Reyes. 2021. Wildfires: Health, Ecological and Economic Impacts – An Overview. (published) 28. Zaman, M.S. and Robert C. Sizemore. 2021. Diverse Manifestations of COVID-19. 2021. Int. J. Env. Res. Pub. Health 18: 9785.

29. Zaman, M.S., Robert C. Sizemore, Suleyman Tufa and Max Carlos Reyes. 2022. Impacts of Wildfires on Human Health, Ecology, and Economy: An Overview. J. Miss. Acad. Sci. 67: 292 – 303.

30. Zaman, M.S. and Robert C. Sziemore. 2022. Massive Wildfires Across the Globe: Could They Be Linked to a Surge in Extreme Weather Conditions. J. Miss. Acad. Sci. 67: 304 – 310.

31. Zaman MS, Sizemore RC. Long COVID: Epidemiology, post-COVID-19 manifestations, possible mechanisms, treatment, and prevention strategies – A review. IMC J Med sci. 2024; 18(2): 003.

32. Sizemore, R.C., Zaman, M.S. 2025. Autoimmune Disorders on the Rise: Pathways to Understanding and Prevention. Journal of Environmental Studies

& Health Research, 1 (1), 1-19.

https://www.doi.org/10.5281/zenodo.14827061 - 6 Jan 2025 33. Zaman, M..S., Robert C. Sizemore and San Juanita Sanchez. 2025. Ocean Acidification: Impacts on Marine Ecosystems and Carbon Sequestration. Journal of Environmental Studies & Health Research, 1 (1). https://www.doi.org/10.5281/zenodo.16934900

34. Zaman, Md.S., Robert C. Sizemore, Draven Rodriguez, Emilio Lopez, S.M. Golam Alam, Suleyman Tufa, Juan C. Lopez-Alvarenga, Nuraly S. Akimbekov, and Mohammed S. Razzaque. 2025. Mpox Insights: From Structure to Human Cell Interaction. J. Mol. Pathol. 6, 29. 9

ABSTRACTS:

1. Sizemore, Robert C. and John M. Mansfield. 1981. Loss of Antigen Nonspecific Suppressor T Cell Function in Experimental African Trypanosomiasis. Fed. Proc. 40:1114.

2. Sizemore, Robert C. and John M. Mansfield. 1982. Intrinsic Loss of Suppressor T Cell Responsiveness in Experimental African Trypanosomiasis. Fed. Proc. 41:578.

3. Sizemore, R.C., N.W. Miller, E. Faulmann and L.W. Clem. 1984. Accessory Cell Involvement in In Vitro Mitogenic Responses of Channel Catfish Leukocytes. Aspects of Developmental and Comparative Immunology II. Dev. Comp. Immunol. Supplement 3, pg. 52.

4. Sizemore, Robert C., Jeffrey L. Farmer and A. Arthur Gottlieb. 1985. Enhancement of Nonspecific Suppressor T Cell Activity by Immunomodulators Derived from Human Leukocyte Dialysates. Fed. Proc. 44:947. 5. Miller, N.W., R.C. Sizemore, A. Deuter and L.W. Clem. 1986. Cellular Requirements for In Vitro Immune Responses with Channel Catfish Leukocytes. Dev. Comp. Immunol. 10:106.

6. Sizemore, Robert C., Sudhir K. Sinha, Shelley A.L. Breeding and A. Arthur Gottlieb. 1986. Suppression of Antigen Dependent Leukocyte and Macrophage Migration Inhibition Factor Activity by a Human Leukocyte Derived Immunomodulator. Fed. Proc. 45:272.

7. Sizemore, Robert C. and A. Arthur Gottlieb. 1986. Enhancement of Con A- Induced Suppressor T Cell and Soluble Immune Suppressor Supernatant Activity by Imreg Immunomodulators. First I.U.I.S. Conference on Clinical Immunology, pg. 63.

8. Sizemore, R.C., S.K. Sinha and A. Arthur Gottlieb. 1987. Effect of Imreg Immunomodulators on the Generation and Activity of Pokeweed Mitogen- Induced Immunoglobulin Secreting Cells. Fed. Proc. 46:1215. 9. Gottlieb, A. A., S.A.L. Breeding, S.K. Sinha and R.C. Sizemore. 1987. Imreg Immunomodulators Enhance Suppressor T Cell Activity Within the CD4 Population. Fed. Proc. 46:472.

10. Sinha, S.K., R.C. Sizemore, D. Merdian, L. Gahn, M. Montag and A. A. Gottlieb. 1987. Purification and Characterization of Low Molecular Weight Immunomodulators from Human Leukocyte Dialysate. Fed. Proc. 46:782. 10

11. Sizemore, R.C., A. A. Gottlieb, S.K. Sinha, E.N. Benes, A.H. Montgomery, C.T. DelSignore and D.C. Bertucci. 1988. Enhancement of Interleukin-2 Receptor Expression on CD4+ Lymphocyte Subsets by IMREG-1, a Leukocyte-Derived Immunomodulator. Clinical Research 36:577A.

12. Sizemore, R.C., R.L. Dienglewicz, R.F. Garry, S.K. Sinha and A. A. Gottlieb. 1988. IMREG-1, a Leukocyte-Derived Immunomodulator, Does Not Enhance HIV Replication in AIDS and ARC Patients. The FASEB Journal 2: A830.

13. Gottlieb, A. A., R.C. Sizemore, A.H. Montgomery and E.N. Benes. 1988. IMREG-1 Augments IL-2 Receptor Expression on CD4+ Lymphocytes of Normal Individuals and Patients with ARC. IV International Conference on AIDS, Book 1, pg. 232.

14. Sizemore, R.C., R.L. Dienglewicz, R.F. Garry, S.K. Sinha, and A. A. Gottlieb. 1988. IMREG-1, A Low Molecular Weight Immunomodulator, Does Not Augment HIV Replication in AIDS/ARC Patients. IV International Conference on AIDS, Book 1, pg. 232.

15. Sizemore, Robert C., Donna C. Bertucci, Ed Benes, Robert L. Dienglewicz, Sudhir K. Sinha, and A. Arthur Gottlieb. 1989. In Vitro Activity of IMREG-1. 7th International Congress of Immunology, Berlin, p. 413. 16. Sizemore, Robert C., Donna C. Bertucci, Eva Pecunia, Sudhir Sinha and A. Arthur Gottlieb. 1990. Modulation of Antigen-Nonspecific Suppressor Cell Activity by Leu-Enkephalin. The FASEB Journal 4: A2044. 17. Benes, Ed, Robert C. Sizemore, Sudhir Sinha, Robert Dienglewicz and A. Arthur Gottlieb. 1990. Effect of IMREG-1 on Intracellular Calcium Levels of Human Peripheral Blood Mononuclear Cells. The FASEB Journal. 4: A1858. 18. Gottlieb, A. A., M.S. Gottlieb, C.H. Kern, III, W. Cantarow and R. Sizemore. 1993. IMREG-1 (A Leukocyte-Dialysate Derived Biopharmaceutical) Enhances Cell Mediated Immunity as Demonstrated by an Effect on Delayed Type Hypersensitivity to Recall Antigens. The 9th International Workshop on Transfer Factor, Beijing China.

19. Gottlieb, A.A,, M.S. Gottlieb, R.C. Sizemore and C.H. Kern III. 1995. Rationale and Clinical Results of Immunosupportive Therapy in Cancer and HIV Disease. Impact of Biotechnology on Predictive Oncology and Therapy: Biomedical Diagnostic and Prognostic Indicators. Boston, MA. Dec. 11-13, 1994. 20. Sizemore, R., C. Kern, M. Gottlieb and A. Gottlieb. 1995. A Novel Methodology For Quantitating the Enhancement of Cutaneous Delayed-Type Hypersensitivity by IMREG-1. The FASEB Journal 9: A237.

11

21. Sizemore, R.C., A.A. Gottlieb, M.S. Gottlieb and C.H.Kern. 1995. Immunomodulation of Cell-mediated Immunity by IMREG-1: Quantitation Of Enhanced DTH Responses in Normal Subjects; Increased Expression of IL-2R

(CD25) on CD4+ Cells of HIV Patients Receiving IMREG-1 Therapy. 1995 International Symposium on Clinical Immunology, San Francisco, CA. 22. Gottlieb, A.A., R.C. Sizemore, M.S. Gottlieb and C.H. Kern. 1995. Rationale and Clinical Results of Using Leukocyte-derived Immunosupportive Therapies in HIV Disease. Xth International Symposium on Transfer Factor. Bologna, Italy. 23. Gottlieb, A.A., R.C. Sizemore, C.H. Kern, and M.S. Gottlieb. 1995. Quantitation of enhanced cutaneous delayed-type hypersensitivity DTH) to tetanus toxoid

(TT) by IMREG-1: A double-blind placebo-controlled study. The Clinical Research Meeting, San Diego, CA.

24. Gottlieb, A., R. Sizemore, C. Kern and M. Gottlieb. 1996. IMREG-2, A Distinct Low Molecular Weight Immunomodulator. The FASEB Journal 10: A1482. 25. Gottlieb, A.A., R.C. Sizemore, C.H. Kern and M.S. Gottlieb. 1996. Immunoregulators Derived from Human Leukocyte Dialysates. Annual Conference on Clinical Immunology, New Orleans, LA. 26. Gottlieb, A. Arthur, R. Sizemore, C. Kern and M. Gottlieb. 1996. IMREG-1 and IMREG-2: Two Investigational Immune-based Therapeutics that Modulate Cell- mediated Immunity. XI International Conference on AIDS. Vancouver, Canada.

27. Park, Heon, A. Arthur Gottlieb, Cilfford H. Kern, III, and Robert C. Sizemore. 1997. Met-enkephalin enhances TH1-type cytokine production by PHA- stimulated peripheral blood mononuclear cells. American Association of Immunologists, San Francisco, CA.

28. Moore, LeeTerry, Angela Cobb, Henry P. Godfrey, Natalia Gordonov, and Robert C. Sizemore. 1999. The Use of Hairless (IAF/HA-HO) Guinea Pigs For The Determination of Delayed-type Hypersensitivity To PPD. National Minority Research Symposium, Phoenix, AZ.

29. Montgomery, Corey, Natalia Gordonov and Robert C. Sizemore. 1999. The effect of met-enkephalin and related peptides on interleukin-2 (IL-2) production. Mississippi Academy of Science, Hattiesburg, MS.

30. Montgomery, Corey, Caleph Wilson, Kristi Isaac, Natalia Gordonov and Robert C. Sizemore. 2000. Modulation of Interleukin-2 (IL-2) Production by Met- enkephalin and Related Peptides. National Minority Research Symposium, Washington, D.C.

12

31. Moore, LeeTerry, Natalia Gordonov, Henry P. Godfrey, Edward Heilman and Robert C. Sizemore. 2000. Effect of Peptides Derived from Enkephalin on Delayed-type Hypersensitivity (DTH) in Hairless Guinea Pigs. National Minority Research Symposium, Washington, D.C.

32. Moore, LeeTerry, Natalia Gordonov, Henry P. Godfrey, Edward Heilman and Robert C. Sizemore. 2001. Effect of Peptides Derived from Enkephalin on Delayed-type Hypersensitivity (DTH) in Hairless Guinea Pigs. Experimental Biology 2001, Late-breaking Abstracts, Orlando, FL. 33. Sizemore, Robert C., Fameeka S. Jenkins, Jimmie K. A. Smith, Jenetria L. Thomas, and Marta Piva. 2003. Modulation of the TH1/TH2 Response in Concanavalin A-stimulated Murine Splenocytes By Peptides Derived From Enkephalin. American Association of Immunologists, Denver, Co. FASEB Journal 17: C80.

34. Carter, Chavez, Marta Piva and Robert C. Sizemore. 2004. Developing a direct competitive enzyme-linked immunoassay to detect methionine- enkephalin in concanavalin A-stimulated murine splenocytes. Fifth National Undergraduate Research Conference, HBCU-UP, at North Carolina A & T. 35. Piva, Marta, J. Ignacio Moreno, Fameeka S. Jenkins, Jimmie K. A. Smith, Jenetria Thomas, Corey Montgomery, Caleph B. Wilson, and Robert C. Sizemore. 2004, The in vitro effects of methionine-enkephalin and its metabolic derivatives YG and YGG on cytokine production by ConA-stimulated murine spleocytes. Experimental Biology 2004, Late-breaking Abstracts, Washington D.C. 36. Newsome, R’shad, Marta Piva and Robert C. Sizemore. 2004. The effect of aging on cytokine production by concanavalin A-stimulated murine splenocytes depends on the mitogen concentration. Twelfth International Congress of Immunology, Montreal, Canada. Clin. Invest. Med. 27: 17A. 37. Carter, Chavez, Marta Piva and Robert C. Sizemore. 2004. Assessing Subnanomolar Concentrations of Endogenous Opioid Peptides by Non- radioactive Methods. Annual Biomedical Research Conference for Minority Students. Dallas, TX.

38. Winston, Marie, Marta Piva and Robert C. Sizemore. 2004. Effect of pH on Interleukin-4 Antigen-antibody Interactions as Assessed by Enzyme-linked Immunoassays. Annual Biomedical Research Conference for Minority Students. Dallas, TX.

39. Piva, M., J.I. Moreno, F.S. Jenkins, J.K.A. Smith, J.L. Thomas, C. Montgomery, C.B. Wilson, and R.C. Sizemore. Immunomodulatory effects of met-enkephalin and its derivatives on cytokine expression: a possible negative feedback 13

mechanism. 2005. 12th Annual Meeting of the Psychoneuroimmunology Research Society, Denver, CO. June 2005.

40. M.S. Zaman and R.C. Sizemore. 2016. Zika Virus: A Public Health Emergency. Third Annual Alcorn State University Centers for Research Excellence Symposium. 3: 19-20.

41. M.S. Zaman and R.C. Sizemore. 2016. Zika Virus: A Mosquito-Borne Virus Raises Alarm in the Americas. J. Miss. Acad. Sci. 62 (1): 140. 42. M.S. Zaman and R. Sizemore. 2018. Freshwater Resources: A Critical Factor in the Sustenance of Human Health and Global Ecosystem. J. Miss. Acad. Sci. 63 (1): 152.

43. R. Sizemore and M. S. Zaman. 2018. Do Squalene-Containing Vaccines Result in the Production of Potentially Harmful Anti-Squalene Antibodies? J. Miss. Acad. Sci. 63 (1): 152-153.

44. Zaman, M.S., Robert C. Sizemore, Suleyman Tufa and Max Carlos Reyes. 2021. Wildfires: Health, Ecological and Economic Impacts – An Overview. (Submitted) PATENTS:

1. Gottlieb, A. Arthur, Robert C. Sizemore and Sudhir K. Sinha. Immunosuppressor and Method of Extraction Thereof. U.S. Patent 4,920,097 issued April 24, 1990.

2. Gottlieb, A. Arthur and Robert C. Sizemore. Methods of and Compositions for Modulating Antibody Production in Treating Patients With AIDS, ARC and Other Diseases. U.S. Patent 5,013,546 issued May 7, 1991.

Contact this candidate